After recent studies showed an increased risk of certainly cardiovascular conditions such as stroke for patients taking rosigilitazone (Avandia), the American Heart Association issued a news release that comments on the studies and provides recommendations, including a statement that metformin should be the first choice when a glucose-lowering medication is needed. Read more here.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder